Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Survival Monitoring in Russian Cancer Registries
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types
- Status
- TERMINATED
- Phase
- PHASE1
A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)
- Status
- RECRUITING
- Phase
- N/A
Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma
- Status
- RECRUITING
- Phase
- PHASE3
Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Head and Neck Melanoma; Access to Staging and Surgical Treatment
- Status
- COMPLETED
- Phase
- N/A
Perioperative Treatment With Tranexamic Acid in Melanoma
- Status
- RECRUITING
- Phase
- PHASE3
Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.
- Status
- RECRUITING
- Phase
- N/A
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Retrospective Assessment of AE-Related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma
- Status
- COMPLETED
- Phase
- N/A